These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23818336)

  • 21. Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination.
    Hebb AL; Moore CS; Bhan V; Campbell T; Fisk JD; Robertson HA; Thorne M; Lacasse E; Holcik M; Gillard J; Crocker SJ; Robertson GS
    Mult Scler; 2008 Jun; 14(5):577-94. PubMed ID: 18566024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
    Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
    J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions.
    Hulshof S; Montagne L; De Groot CJ; Van Der Valk P
    Glia; 2002 Apr; 38(1):24-35. PubMed ID: 11921201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity.
    Wiendl H; Feger U; Mittelbronn M; Jack C; Schreiner B; Stadelmann C; Antel J; Brueck W; Meyermann R; Bar-Or A; Kieseier BC; Weller M
    Brain; 2005 Nov; 128(Pt 11):2689-704. PubMed ID: 16123145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid cell plasticity in the evolution of central nervous system autoimmunity.
    Giles DA; Washnock-Schmid JM; Duncker PC; Dahlawi S; Ponath G; Pitt D; Segal BM
    Ann Neurol; 2018 Jan; 83(1):131-141. PubMed ID: 29283442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis.
    Honardoost MA; Kiani-Esfahani A; Ghaedi K; Etemadifar M; Salehi M
    Gene; 2014 Jul; 544(2):128-33. PubMed ID: 24792898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased expression of distinct galectins in multiple sclerosis lesions.
    Stancic M; van Horssen J; Thijssen VL; Gabius HJ; van der Valk P; Hoekstra D; Baron W
    Neuropathol Appl Neurobiol; 2011 Oct; 37(6):654-71. PubMed ID: 21501208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.
    Ifergan I; Kebir H; Terouz S; Alvarez JI; Lécuyer MA; Gendron S; Bourbonnière L; Dunay IR; Bouthillier A; Moumdjian R; Fontana A; Haqqani A; Klopstein A; Prinz M; López-Vales R; Birchler T; Prat A
    Ann Neurol; 2011 Nov; 70(5):751-63. PubMed ID: 22162058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.
    Junker A; Krumbholz M; Eisele S; Mohan H; Augstein F; Bittner R; Lassmann H; Wekerle H; Hohlfeld R; Meinl E
    Brain; 2009 Dec; 132(Pt 12):3342-52. PubMed ID: 19952055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis.
    Saikali P; Antel JP; Pittet CL; Newcombe J; Arbour N
    J Immunol; 2010 Nov; 185(10):5693-703. PubMed ID: 20926794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Absence of miRNA-146a Differentially Alters Microglia Function and Proteome.
    Martin NA; Hyrlov KH; Elkjaer ML; Thygesen EK; Wlodarczyk A; Elbaek KJ; Aboo C; Okarmus J; Benedikz E; Reynolds R; Hegedus Z; Stensballe A; Svenningsen ÅF; Owens T; Illes Z
    Front Immunol; 2020; 11():1110. PubMed ID: 32582192
    [No Abstract]   [Full Text] [Related]  

  • 33. Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS.
    Prinz M; Priller J
    J Neuroimmunol; 2010 Jul; 224(1-2):80-4. PubMed ID: 20554025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage-Microglia Networks Drive M1 Microglia Polarization After Mycobacterium Infection.
    Qin Y; Sun X; Shao X; Cheng C; Feng J; Sun W; Gu D; Liu W; Xu F; Duan Y
    Inflammation; 2015 Aug; 38(4):1609-16. PubMed ID: 25687640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TMEM119 marks a subset of microglia in the human brain.
    Satoh J; Kino Y; Asahina N; Takitani M; Miyoshi J; Ishida T; Saito Y
    Neuropathology; 2016 Feb; 36(1):39-49. PubMed ID: 26250788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
    Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
    Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation.
    Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
    Leukemia; 2013 Feb; 27(2):377-88. PubMed ID: 22828446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both miR-17-5p and miR-20a alleviate suppressive potential of myeloid-derived suppressor cells by modulating STAT3 expression.
    Zhang M; Liu Q; Mi S; Liang X; Zhang Z; Su X; Liu J; Chen Y; Wang M; Zhang Y; Guo F; Zhang Z; Yang R
    J Immunol; 2011 Apr; 186(8):4716-24. PubMed ID: 21383238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD163-positive perivascular macrophages in the human CNS express molecules for antigen recognition and presentation.
    Fabriek BO; Van Haastert ES; Galea I; Polfliet MM; Döpp ED; Van Den Heuvel MM; Van Den Berg TK; De Groot CJ; Van Der Valk P; Dijkstra CD
    Glia; 2005 Sep; 51(4):297-305. PubMed ID: 15846794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
    Mehta V; Pei W; Yang G; Li S; Swamy E; Boster A; Schmalbrock P; Pitt D
    PLoS One; 2013; 8(3):e57573. PubMed ID: 23516409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.